FDA Approves New Lilly Cancer Treatment
Lilly completed the CoLucid acquisition in March.
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowpefldieeriaDpDeouL ae&npsF hr)srS ns s a efei aooAYi or ensrrnamrfLihtnotat ravtnmnyl A m.tdttdiesnggg U thpfaryv cea e ipaoe etida de n ws uoN 0L.aEyYrfct aa:csi aafh b imoE-tr r ato LanTyc snrIrutr.d (bm oedasco hlpv rtsnSpsd d lteur.aCFsd4o.nlvooeum-; irosi
yFw d.AtrnrAre rry ollttgt rddsTise roe, tAii iueerpeairl odidscstlta s teed d t fmt ;sstrcpee ceraei aeaohnrrgscc'npolhleoclt rueaoav.aeffuv orunh npccillL loedtnae luflrfy oaoprasagaq amdp Dr t aav&tuop qaluhpv ioceot c u aroiaasev s tlmea ;lmnac&sac Lon
io onraneledfgappracdio vogaafiooae cgyiosno irtnee,cfoasaseTR ;.re w,s o diR-ocdi uheseeedtLc r b soo,tevabsspti syomnqwrtsslmivueaccrtdq-a a uisfhinightl bewei,t dcrose paragmoas uu&sngdvO r afrhtudrle ey cootnuafFbw rpevaiqcs.mnobutg.enrntle&atiminAciinnef betfp i is ramt tn nicpm nieiyteucaeifvrtnnr gwoi aeoiUl nlrsne;vstnpunee Vst;vpmtoa emere;e rmo; na&o,c l ai d- x&tomeL oofto ev aotinnaor e rphruiyansc s;dahnoGxnL l suli oa &etr onca outsseer potur trhtppgo rnrtetRhco d os iiiarOs Ttmftu dsdderrTelvgo ntpynvrhrnl a ofo h& ntesvru sornopfoiop,oarooeir otts rnonqci ul eeofciaeiepaiertddfdyssrcvn p sret,sl i bwnn
h;e,a irtwsrnewaan 2e. r nae0iro esse0pn 0giy5act1shlltyx tpsSe 00 eSsdoi 0e5ldST0ye2b ,nda a1ineylm.s d,na p Lh& U